{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,12,23]],"date-time":"2025-12-23T06:31:36Z","timestamp":1766471496446,"version":"3.40.5"},"reference-count":70,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2025,5,14]],"date-time":"2025-05-14T00:00:00Z","timestamp":1747180800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2025,5,14]],"date-time":"2025-05-14T00:00:00Z","timestamp":1747180800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"funder":[{"name":"Beijing Association for Science and Technology Jinqiao Project for \u201cAnalysis of Clinical Characteristics and Risk Factors for Persistent SARS-CoV-2 Infection\u201d","award":["SK20240040"],"award-info":[{"award-number":["SK20240040"]}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["BMC Infect Dis"],"DOI":"10.1186\/s12879-025-11083-2","type":"journal-article","created":{"date-parts":[[2025,5,14]],"date-time":"2025-05-14T11:36:11Z","timestamp":1747222571000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":2,"title":["In-depth analysis of the risk factors for persistent severe acute respiratory syndrome coronavirus 2 infection and construction of predictive models: an exploratory research study"],"prefix":"10.1186","volume":"25","author":[{"given":"Jia","family":"Zhang","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Weihua","family":"Zhu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Piping","family":"Jiang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Feng","family":"Ma","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yulin","family":"Li","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yuwei","family":"Cao","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jiaxin","family":"Li","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Zhe","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Xin","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Wailong","family":"Zou","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jichao","family":"Chen","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2025,5,14]]},"reference":[{"key":"11083_CR1","doi-asserted-by":"publisher","first-page":"116","DOI":"10.1016\/j.jclinepi.2023.08.002","volume":"161","author":"O Dewidar","year":"2023","unstructured":"Dewidar O, Bondok M, Abdelrazeq L, Aliyeva K, Solo K, Welch V, et al. Equity issues rarely addressed in the development of COVID-19 formal recommendations and good practice statements: a cross-sectional study. J Clin Epidemiol. 2023;161:116\u201326. https:\/\/doi.org\/10.1016\/j.jclinepi.2023.08.002.","journal-title":"J Clin Epidemiol"},{"key":"11083_CR2","doi-asserted-by":"publisher","first-page":"e453","DOI":"10.1016\/S1473-3099(23)00815-0","volume":"24","author":"HM Machkovech","year":"2024","unstructured":"Machkovech HM, Hahn AM, Garonzik Wang J, Grubaugh ND, Halfmann PJ, Johnson MC, et al. Persistent SARS-CoV-2 infection: significance and implications. Lancet Infect Dis. 2024;24:e453\u201362. https:\/\/doi.org\/10.1016\/S1473-3099(23)00815-0.","journal-title":"Lancet Infect Dis"},{"key":"11083_CR3","doi-asserted-by":"publisher","DOI":"10.1111\/irv.70006","volume":"18","author":"Y Gao","year":"2024","unstructured":"Gao Y, Dong Y, Bu Q, Gong Z, Wang W, Zhou Z, et al. Antiviral effectiveness, clinical outcomes, and artificial intelligence imaging analysis for hospitalized COVID-19 patients receiving antivirals. Influenza Other Respir Viruses. 2024;18: e70006. https:\/\/doi.org\/10.1111\/irv.70006.","journal-title":"Influenza Other Respir Viruses"},{"key":"11083_CR4","doi-asserted-by":"publisher","first-page":"1501","DOI":"10.1038\/s41591-022-01882-4","volume":"28","author":"S Harari","year":"2022","unstructured":"Harari S, Tahor M, Rutsinsky N, Meijer S, Miller D, Henig O, et al. Drivers of adaptive evolution during chronic SARS-CoV-2 infections. Nat Med. 2022;28:1501\u20138. https:\/\/doi.org\/10.1038\/s41591-022-01882-4.","journal-title":"Nat Med"},{"key":"11083_CR5","doi-asserted-by":"publisher","DOI":"10.1016\/j.xcrm.2023.100943","volume":"2","author":"C Chaguza","year":"2023","unstructured":"Chaguza C, Hahn AM, Petrone ME, Zhou S, Ferguson D, Breban MI, et al. Accelerated SARS-CoV-2 intrahost evolution leading to distinct genotypes during chronic infection. Cell Rep Med. 2023;2: 100943. https:\/\/doi.org\/10.1016\/j.xcrm.2023.100943.","journal-title":"Cell Rep Med"},{"key":"11083_CR6","doi-asserted-by":"publisher","first-page":"veac050","DOI":"10.1093\/ve\/veac050","volume":"8","author":"SAJ Wilkinson","year":"2022","unstructured":"Wilkinson SAJ, Richter A, Casey A, Osman H, Mirza JD, Stockton J, et al. Recurrent SARS-CoV-2 mutations in immunodeficient patients. Virus Evol. 2022;8:veac050. https:\/\/doi.org\/10.1093\/ve\/veac050.","journal-title":"Virus Evol."},{"key":"11083_CR7","doi-asserted-by":"publisher","first-page":"e13","DOI":"10.1016\/S2666-5247(20)30172-5","volume":"2","author":"M Cevik","year":"2021","unstructured":"Cevik M, Tate M, Lloyd O, Maraolo AE, Schafers J, Ho A. SARS-CoV-2, SARS-CoV, and MERS-CoV viral load dynamics, duration of viral shedding, and infectiousness: a systematic review and meta-analysis. Lancet Microbe. 2021;2:e13-22. https:\/\/doi.org\/10.1016\/S2666-5247(20)30172-5.","journal-title":"Lancet Microbe"},{"key":"11083_CR8","doi-asserted-by":"publisher","unstructured":"Li Y, Choudhary MC, Regan J, Boucau J, Nathan A, Speidel T, et al. SARS-CoV-2 viral clearance and evolution varies by extent of immunodeficiency. medRxiv. 2023:2023.07.31.23293441. https:\/\/doi.org\/10.1101\/2023.07.31.23293441 (preprint).","DOI":"10.1101\/2023.07.31.23293441"},{"key":"11083_CR9","doi-asserted-by":"publisher","first-page":"3235","DOI":"10.1038\/s41467-023-38867-x","volume":"14","author":"AS Gonzalez-Reiche","year":"2023","unstructured":"Gonzalez-Reiche AS, Alshammary H, Schaefer S, Patel G, Polanco J, Carre\u00f1o JM, et al. Sequential intrahost evolution and onward transmission of SARS-CoV-2 variants. Nat Commun. 2023;14:3235. https:\/\/doi.org\/10.1038\/s41467-023-38867-x.","journal-title":"Nat Commun"},{"key":"11083_CR10","doi-asserted-by":"publisher","first-page":"2436","DOI":"10.1056\/NEJMc2202861","volume":"386","author":"EM Scherer","year":"2022","unstructured":"Scherer EM, Babiker A, Adelman MW, Allman B, Key A, Kleinhenz JM, et al. SARS-CoV-2 evolution and immune escape in immunocompromised patients. N Engl J Med. 2022;386:2436\u20138. https:\/\/doi.org\/10.1056\/NEJMc2202861.","journal-title":"N Engl J Med"},{"key":"11083_CR11","doi-asserted-by":"publisher","first-page":"veac104","DOI":"10.1093\/ve\/veac104","volume":"9","author":"PJ Halfmann","year":"2023","unstructured":"Halfmann PJ, Minor NR, Haddock LA 3rd, Maddox R, Moreno GK, Braun KM, et al. Evolution of a globally unique SARS-CoV-2 Spike E484T monoclonal antibody escape mutation in a persistently infected, immunocompromised individual. Virus Evol. 2023;9:veac104. https:\/\/doi.org\/10.1093\/ve\/veac104.","journal-title":"Virus Evol."},{"key":"11083_CR12","doi-asserted-by":"publisher","first-page":"1257433","DOI":"10.3389\/fcimb.2023.1257433","volume":"13","author":"V Zymovets","year":"2023","unstructured":"Zymovets V, Rakhimova O, Wadelius P, Schmidt A, Brundin M, Kelk P, et al. Exploring the impact of oral bacteria remnants on stem cells from the Apical papilla: mineralization potential and inflammatory response. Front Cell Infect Microbiol. 2023;13:1257433. https:\/\/doi.org\/10.3389\/fcimb.2023.1257433.","journal-title":"Front Cell Infect Microbiol"},{"key":"11083_CR13","doi-asserted-by":"publisher","first-page":"62","DOI":"10.1158\/2159-8290.CD-21-1033","volume":"12","author":"CY Lee","year":"2022","unstructured":"Lee CY, Shah MK, Hoyos D, Solovyov A, Douglas M, Taur Y, et al. Prolonged SARS-CoV-2 infection in patients with lymphoid malignancies. Cancer Discov. 2022;12:62\u201373. https:\/\/doi.org\/10.1158\/2159-8290.CD-21-1033.","journal-title":"Cancer Discov"},{"key":"11083_CR14","doi-asserted-by":"publisher","first-page":"562","DOI":"10.1056\/NEJMsb2104756","volume":"385","author":"L Corey","year":"2021","unstructured":"Corey L, Beyrer C, Cohen MS, Michael NL, Bedford T, Rolland M. SARS-CoV-2 variants in patients with immunosuppression. N Engl J Med. 2021;385:562\u20136. https:\/\/doi.org\/10.1056\/NEJMsb2104756.","journal-title":"N Engl J Med"},{"key":"11083_CR15","doi-asserted-by":"publisher","first-page":"56","DOI":"10.1016\/j.jaci.2022.05.001","volume":"150","author":"CM Connolly","year":"2022","unstructured":"Connolly CM, Paik JJ. SARS-CoV-2 vaccination in the immunocompromised host. J Allergy Clin Immunol. 2022;150:56\u20138. https:\/\/doi.org\/10.1016\/j.jaci.2022.05.001.","journal-title":"J Allergy Clin Immunol"},{"key":"11083_CR16","doi-asserted-by":"publisher","DOI":"10.2196\/31549","volume":"24","author":"F He","year":"2022","unstructured":"He F, Page JH, Weinberg KR, Mishra A. The development and validation of simplified machine learning algorithms to predict prognosis of hospitalized patients with COVID-19: multicenter, retrospective study. J Med Internet Res. 2022;24: e31549. https:\/\/doi.org\/10.2196\/31549.","journal-title":"J Med Internet Res"},{"key":"11083_CR17","doi-asserted-by":"publisher","DOI":"10.3389\/fmed.2021.663670","volume":"8","author":"ATM Mohiuddin Chowdhury","year":"2021","unstructured":"Mohiuddin Chowdhury ATM, Karim MR, Ali MA, Islam J, Li Y, He S. Clinical characteristics and the long-term post-recovery manifestations of the COVID-19 patients-A prospective multicenter cross-sectional study. Front Med (Lausanne). 2021;8: 663670. https:\/\/doi.org\/10.3389\/fmed.2021.663670.","journal-title":"Front Med (Lausanne)"},{"key":"11083_CR18","doi-asserted-by":"publisher","first-page":"64","DOI":"10.1038\/s41401-021-00627-2","volume":"43","author":"XQ Liu","year":"2022","unstructured":"Liu XQ, Xue S, Xu JB, Ge H, Mao Q, Xu XH, et al. Clinical characteristics and related risk factors of disease severity in 101 COVID-19 patients hospitalized in Wuhan. China Acta Pharmacol Sin. 2022;43:64\u201375. https:\/\/doi.org\/10.1038\/s41401-021-00627-2.","journal-title":"China Acta Pharmacol Sin"},{"key":"11083_CR19","doi-asserted-by":"publisher","DOI":"10.1016\/j.heliyon.2023.e15233","volume":"9","author":"ML Acedera","year":"2023","unstructured":"Acedera ML, Sirichokchatchawan W, Brimson S, Prasansuklab A. Age, comorbidities, C-reactive protein and procalcitonin as predictors of severity in confirmed COVID-19 patients in the Philippines. Heliyon. 2023;9: e15233. https:\/\/doi.org\/10.1016\/j.heliyon.2023.e15233.","journal-title":"Heliyon"},{"key":"11083_CR20","doi-asserted-by":"publisher","first-page":"458","DOI":"10.15585\/mmwr.mm6915e3","volume":"69","author":"S Garg","year":"2020","unstructured":"Garg S, Kim L, Whitaker M, O\u2019Halloran A, Cummings C, Holstein R, et al. Hospitalization rates and characteristics of patients hospitalized with laboratory-confirmed coronavirus disease 2019 - COVID-NET, 14 States, March 1\u201330, 2020. MMWR Morb Mortal Wkly Rep. 2020;69:458\u201364. https:\/\/doi.org\/10.15585\/mmwr.mm6915e3.","journal-title":"MMWR Morb Mortal Wkly Rep."},{"key":"11083_CR21","doi-asserted-by":"publisher","unstructured":"National Health Commission of the People\u2019s Republic of China. Diagnosis and treatment protocol for COVID-19 (Trial 10th Edition) [in Chinese].\u00a0Chin J Clin Infect Dis.\u00a02023;16:1\u20139. https:\/\/doi.org\/10.3760\/cma.j.issn.1674-2397.2023.01.001.","DOI":"10.3760\/cma.j.issn.1674-2397.2023.01.001"},{"key":"11083_CR22","doi-asserted-by":"publisher","first-page":"e102","DOI":"10.1016\/S1473-3099(21)00703-9","volume":"22","author":"JB Soriano","year":"2022","unstructured":"Soriano JB, Murthy S, Marshall JC, Relan P, Diaz JV, WHO Clinical Case Definition Working Group on Post-COVID-19 Condition. A clinical case definition of post-COVID-19 condition by a Delphi consensus. Lancet Infect Dis. 2022;22:e102-7. https:\/\/doi.org\/10.1016\/S1473-3099(21)00703-9.","journal-title":"Lancet Infect Dis."},{"key":"11083_CR23","doi-asserted-by":"publisher","first-page":"1715","DOI":"10.3758\/s13428-023-02117-1","volume":"56","author":"E Costantini","year":"2024","unstructured":"Costantini E, Lang KM, Sijtsma K, Reeskens T. Solving the many-variables problem in MICE with principal component regression. Behav Res Methods. 2024;56:1715\u201337. https:\/\/doi.org\/10.3758\/s13428-023-02117-1.","journal-title":"Behav Res Methods"},{"key":"11083_CR24","doi-asserted-by":"publisher","unstructured":"N\u00fa\u00f1ez E, Steyerberg EW, N\u00fa\u00f1ez J. Estrategias para la elaboraci\u00f3n de modelos estad\u00edsticos de regresi\u00f3n [Regression modeling strategies]. Rev Esp Cardiol. 2011;64:501\u20137. https:\/\/doi.org\/10.1016\/j.recesp.2011.01.019. Spanish.","DOI":"10.1016\/j.recesp.2011.01.019"},{"key":"11083_CR25","unstructured":"World Health Organization. Clinical management of COVID-19: living guideline; 2023. https:\/\/www.who.int\/publications\/i\/item\/WHO-2019-nCoV-clinical-2023.2."},{"key":"11083_CR26","doi-asserted-by":"publisher","first-page":"2400312","DOI":"10.1080\/07853890.2024.2400312","volume":"56","author":"A Zhao","year":"2024","unstructured":"Zhao A, Liu Y, Xia J, Huang L, Lu Q, Tang Q, et al. Establishment and validation of a prognostic model based on common laboratory indicators for SARS-CoV-2 infection in Chinese population. Ann Med. 2024;56:2400312. https:\/\/doi.org\/10.1080\/07853890.2024.2400312.","journal-title":"Ann Med"},{"key":"11083_CR27","doi-asserted-by":"publisher","unstructured":"Tang J, Zeng C, Cox TM, Li C, Son YM, Cheon IS, et al. Respiratory mucosal immunity against SARS-CoV-2 after mRNA vaccination. Sci Immunol. 202228;7:eadd4853. https:\/\/doi.org\/10.1126\/sciimmunol.add4853.","DOI":"10.1126\/sciimmunol.add4853"},{"key":"11083_CR28","doi-asserted-by":"publisher","unstructured":"Hettle D, Hutchings S, Muir P, Moran E; COVID-19 Genomics UK (COG-UK) consortium. Persistent SARS-CoV-2 infection in immunocompromised patients facilitates rapid viral evolution: Retrospective cohort study and literature review. Clin Infect Pract. 2022;16:100210. https:\/\/doi.org\/10.1016\/j.clinpr.2022.100210.","DOI":"10.1016\/j.clinpr.2022.100210"},{"key":"11083_CR29","doi-asserted-by":"publisher","first-page":"1603","DOI":"10.1007\/s00134-024-07613-2","volume":"50","author":"E Crescioli","year":"2024","unstructured":"Crescioli E, Nielsen FM, Bunzel AM, Eriksen ASB, Siegemund M, Poulsen LM, et al. Long-term mortality and health-related quality of life with lower versus higher oxygenation targets in intensive care unit patients with COVID-19 and severe hypoxaemia. Intensive Care Med. 2024;50:1603\u201313. https:\/\/doi.org\/10.1007\/s00134-024-07613-2.","journal-title":"Intensive Care Med"},{"key":"11083_CR30","doi-asserted-by":"publisher","first-page":"430","DOI":"10.1038\/s41586-020-2521-4","volume":"584","author":"EJ Williamson","year":"2020","unstructured":"Williamson EJ, Walker AJ, Bhaskaran K, Bacon S, Bates C, Morton CE, et al. Factors associated with COVID-19-related death using Open SAFELY. Nature. 2020;584:430\u20136. https:\/\/doi.org\/10.1038\/s41586-020-2521-4.","journal-title":"Nature"},{"key":"11083_CR31","doi-asserted-by":"publisher","first-page":"e202101314","DOI":"10.26508\/lsa.202101314","volume":"5","author":"E Speranza","year":"2022","unstructured":"Speranza E, Purushotham JN, Port JR, Schwarz B, Flagg M, Williamson BN, et al. Age-related differences in immune dynamics during SARS-CoV-2 infection in rhesus macaques. Life Sci Alliance. 2022;5:e202101314. https:\/\/doi.org\/10.26508\/lsa.202101314.","journal-title":"Life Sci Alliance."},{"key":"11083_CR32","doi-asserted-by":"publisher","first-page":"890","DOI":"10.3390\/v13050890","volume":"13","author":"M Drancourt","year":"2021","unstructured":"Drancourt M, Cortaredona S, Melenotte C, Amrane S, Eldin C, La Scola B, et al. SARS-CoV-2 persistent viral shedding in the context of hydroxychloroquine-azithromycin treatment. Viruses. 2021;13:890. https:\/\/doi.org\/10.3390\/v13050890.","journal-title":"Viruses"},{"key":"11083_CR33","doi-asserted-by":"publisher","DOI":"10.1002\/jcla.25005","volume":"38","author":"T Hoseinnezhad","year":"2024","unstructured":"Hoseinnezhad T, Soltani N, Ziarati S, Behboudi E, Mousavi MJ. The role of HLA genetic variants in COVID-19 susceptibility, severity, and mortality: A global review. J Clin Lab Anal. 2024;38: e25005. https:\/\/doi.org\/10.1002\/jcla.25005.","journal-title":"J Clin Lab Anal"},{"key":"11083_CR34","doi-asserted-by":"publisher","first-page":"e26577","DOI":"10.1016\/j.heliyon.2024.e26577","volume":"10","author":"E Behboudi","year":"2024","unstructured":"Behboudi E, Nooreddin Faraji S, Daryabor G. Mohammad Ali Hashemi S, Asadi M, Edalat F, et al, SARS-CoV-2 mechanisms of cell tropism in various organs considering host factors. Heliyon. 2024;10:e26577. https:\/\/doi.org\/10.1016\/j.heliyon.2024.e26577.","journal-title":"Heliyon."},{"key":"11083_CR35","doi-asserted-by":"publisher","unstructured":"Ayatollahi AA, Aghcheli B, Amini A, Nikbakht H, Ghassemzadehpirsala P, Behboudi E, et al. Association between blood groups and COVID-19 outcome in Iranian patients. Future Virol. 2021:https:\/\/doi.org\/10.2217\/fvl-2021-0090. https:\/\/doi.org\/10.2217\/fvl-2021-0090.","DOI":"10.2217\/fvl-2021-0090"},{"issue":"14","key":"11083_CR36","doi-asserted-by":"publisher","first-page":"10462","DOI":"10.1038\/s41598-024-61360-4","volume":"7","author":"SJ Kim","year":"2024","unstructured":"Kim SJ, Kim T, Choi H, Shin TR, Kim HI, Jang SH, et al. Respiratory pathogen and clinical features of hospitalized patients in acute exacerbation of chronic obstructive pulmonary disease after COVID 19 pandemic. Sci Rep. 2024;7(14):10462. https:\/\/doi.org\/10.1038\/s41598-024-61360-4.","journal-title":"Sci Rep"},{"key":"11083_CR37","doi-asserted-by":"publisher","DOI":"10.3389\/fmed.2021.709006","volume":"8","author":"R Xiong","year":"2021","unstructured":"Xiong R, Zhao Z, Lu H, Ma Y, Zeng H, Chen Y. Asthma patients benefit more than chronic obstructive pulmonary disease patients in the coronavirus disease 2019 pandemic. Front Med (Lausanne). 2021;8: 709006. https:\/\/doi.org\/10.3389\/fmed.2021.709006.","journal-title":"Front Med (Lausanne)"},{"key":"11083_CR38","doi-asserted-by":"publisher","first-page":"293","DOI":"10.3389\/fmicb.2013.00293","volume":"4","author":"D Kurai","year":"2013","unstructured":"Kurai D, Saraya T, Ishii H, Takizawa H. Virus-induced exacerbations in asthma and COPD. Front Microbiol. 2013;4:293. https:\/\/doi.org\/10.3389\/fmicb.2013.00293.","journal-title":"Front Microbiol"},{"key":"11083_CR39","doi-asserted-by":"publisher","first-page":"1730","DOI":"10.1111\/all.14238","volume":"75","author":"JJ Zhang","year":"2020","unstructured":"Zhang JJ, Dong X, Cao YY, Yuan YD, Yang YB, Yan YQ, et al. Clinical characteristics of 140 patients infected with SARS-CoV-2 in Wuhan. China In: Allergy. 2020;75:1730\u201341. https:\/\/doi.org\/10.1111\/all.14238.","journal-title":"China In: Allergy"},{"key":"11083_CR40","doi-asserted-by":"publisher","first-page":"875","DOI":"10.1038\/nm1267","volume":"11","author":"K Kuba","year":"2005","unstructured":"Kuba K, Imai Y, Rao S, Gao H, Guo F, Guan B, et al. A crucial role of angiotensin converting enzyme 2 (ACE2) in SARS coronavirus-induced lung injury. Nat Med. 2005;11:875\u20139. https:\/\/doi.org\/10.1038\/nm1267.","journal-title":"Nat Med"},{"key":"11083_CR41","doi-asserted-by":"publisher","first-page":"814","DOI":"10.1007\/s00109-006-0094-9","volume":"84","author":"K Kuba","year":"2006","unstructured":"Kuba K, Imai Y, Rao S, Jiang C, Penninger JM. Lessons from SARS: control of acute lung failure by the SARS receptor ACE2. J Mol Med (Berl). 2006;84:814\u201320. https:\/\/doi.org\/10.1007\/s00109-006-0094-9.","journal-title":"J Mol Med (Berl)"},{"key":"11083_CR42","doi-asserted-by":"publisher","first-page":"742","DOI":"10.1182\/blood.2022018903","volume":"142","author":"SC Wu","year":"2023","unstructured":"Wu SC, Arthur CM, Jan HM, Garcia-Beltran WF, Patel KR, Rathgeber MF, et al. Blood group A enhances SARS-CoV-2 infection. Blood. 2023;142:742\u20137. https:\/\/doi.org\/10.1182\/blood.2022018903.","journal-title":"Blood"},{"key":"11083_CR43","doi-asserted-by":"publisher","first-page":"385","DOI":"10.31083\/j.rcm.2020.03.78","volume":"21","author":"N Deravi","year":"2020","unstructured":"Deravi N, Fathi M, Vakili K, Yaghoobpoor S, Pirzadeh M, Mokhtari M, et al. SARS-CoV-2 infection in patients with diabetes mellitus and hypertension: a systematic review. Rev Cardiovasc Med. 2020;21:385\u201397. https:\/\/doi.org\/10.31083\/j.rcm.2020.03.78.","journal-title":"Rev Cardiovasc Med."},{"key":"11083_CR44","doi-asserted-by":"publisher","first-page":"746","DOI":"10.3390\/v14040746","volume":"14","author":"K W\u00fcnsch","year":"2022","unstructured":"W\u00fcnsch K, Anastasiou OE, Alt M, Brochhagen L, Cherneha M, Th\u00fcmmler L, et al. COVID-19 in elderly, immunocompromised or diabetic patients-from immune monitoring to clinical management in the hospital. Viruses. 2022;14:746. https:\/\/doi.org\/10.3390\/v14040746.","journal-title":"Viruses."},{"key":"11083_CR45","doi-asserted-by":"publisher","first-page":"1482","DOI":"10.1016\/S0140-6736(21)02096-1","volume":"398","author":"M Prendecki","year":"2021","unstructured":"Prendecki M, Thomson T, Clarke CL, Martin P, Gleeson S, De Aguiar RC, et al. Immunological responses to SARS-CoV-2 vaccines in kidney transplant recipients. Lancet. 2021;398:1482\u20134. https:\/\/doi.org\/10.1016\/S0140-6736(21)02096-1.","journal-title":"Lancet"},{"key":"11083_CR46","doi-asserted-by":"publisher","first-page":"925","DOI":"10.1111\/ajt.16449","volume":"21","author":"L Danziger-Isakov","year":"2021","unstructured":"Danziger-Isakov L, Blumberg EA, Manuel O, Sester M. Impact of COVID-19 in solid organ transplant recipients. Am J Transplant. 2021;21:925\u201337. https:\/\/doi.org\/10.1111\/ajt.16449.","journal-title":"Am J Transplant"},{"key":"11083_CR47","doi-asserted-by":"publisher","unstructured":"Lee JC, Mehdizadeh S, Smith J, Young A, Mufazalov IA, Mowery CT, et al. Regulatory T cell control of systemic immunity and immunotherapy response in liver metastasis. Sci Immunol. 2020;5:eaba0759. https:\/\/doi.org\/10.1126\/sciimmunol.aba0759.","DOI":"10.1126\/sciimmunol.aba0759"},{"key":"11083_CR48","doi-asserted-by":"publisher","first-page":"1080","DOI":"10.1016\/10.3390\/vaccines11061080","volume":"11","author":"E Emmanouilidou-Fotoulaki","year":"2023","unstructured":"Emmanouilidou-Fotoulaki E, Karava V, Dotis J, Kondou A, Printza N. Immunologic response to SARS-CoV-2 vaccination in pediatric kidney transplant recipients: a systematic review and meta-analysis. Vaccines (Basel). 2023;11:1080. https:\/\/doi.org\/10.1016\/10.3390\/vaccines11061080.","journal-title":"Vaccines (Basel)"},{"key":"11083_CR49","doi-asserted-by":"publisher","first-page":"847","DOI":"10.1016\/j.cell.2022.01.015","volume":"185","author":"A Tarke","year":"2022","unstructured":"Tarke A, Coelho CH, Zhang Z, Dan JM, Yu ED, Methot N, et al. SARS-CoV-2 vaccination induces immunological T cell memory able to cross-recognize variants from Alpha to Omicron. Cell. 2022;185:847-59.e11. https:\/\/doi.org\/10.1016\/j.cell.2022.01.015.","journal-title":"Cell"},{"key":"11083_CR50","doi-asserted-by":"publisher","first-page":"161","DOI":"10.1002\/jmv.27285","volume":"94","author":"FAT Boshier","year":"2022","unstructured":"Boshier FAT, Pang J, Penner J, Parker M, Alders N, Bamford A, et al. Evolution of viral variants in remdesivir-treated and untreated SARS-CoV-2-infected pediatrics patients. J Med Virol. 2022;94:161\u201372. https:\/\/doi.org\/10.1002\/jmv.27285.","journal-title":"J Med Virol"},{"key":"11083_CR51","doi-asserted-by":"publisher","first-page":"200","DOI":"10.1038\/s41392-023-01451-2","volume":"8","author":"Z Liu","year":"2023","unstructured":"Liu Z, Liang Q, Ren Y, Guo C, Ge X, Wang L, et al. Immunosenescence: molecular mechanisms and diseases. Signal Transduct Target Ther. 2023;8:200. https:\/\/doi.org\/10.1038\/s41392-023-01451-2.","journal-title":"Signal Transduct Target Ther"},{"key":"11083_CR52","doi-asserted-by":"publisher","first-page":"511","DOI":"10.1038\/s41591-020-0799-2","volume":"26","author":"SW Kazer","year":"2020","unstructured":"Kazer SW, Aicher TP, Muema DM, Carroll SL, Ordovas-Montanes J, Miao VN, et al. Integrated single-cell analysis of multicellular immune dynamics during hyperacute HIV-1 infection. Nat Med. 2020;26:511\u20138. https:\/\/doi.org\/10.1038\/s41591-020-0799-2.","journal-title":"Nat Med"},{"key":"11083_CR53","doi-asserted-by":"publisher","first-page":"271","DOI":"10.1097\/QCO.0000000000000841","volume":"35","author":"JC Laracy","year":"2022","unstructured":"Laracy JC, Kamboj M, Vardhana SA. Long and persistent COVID-19 in patients with hematologic malignancies: from bench to bedside. Curr Opin Infect Dis. 2022;35:271\u20139. https:\/\/doi.org\/10.1097\/QCO.0000000000000841.","journal-title":"Curr Opin Infect Dis"},{"key":"11083_CR54","doi-asserted-by":"publisher","first-page":"1083","DOI":"10.1007\/s10875-023-01504-9","volume":"43","author":"M Chan","year":"2023","unstructured":"Chan M, Linn MMN, O\u2019Hagan T, Guerra-Assun\u00e7\u00e3o JA, Lackenby A, Workman S, et al. Persistent SARS-CoV-2 PCR positivity despite anti-viral treatment in immunodeficient patients. J Clin Immunol. 2023;43:1083\u201392. https:\/\/doi.org\/10.1007\/s10875-023-01504-9.","journal-title":"J Clin Immunol"},{"key":"11083_CR55","doi-asserted-by":"publisher","first-page":"1280","DOI":"10.1038\/s41591-021-01386-7","volume":"27","author":"EM Bange","year":"2021","unstructured":"Bange EM, Han NA, Wileyto P, Kim JY, Gouma S, Robinson J, et al. CD8+ T cells contribute to survival in patients with COVID-19 and hematologic cancer. Nat Med. 2021;27:1280\u20139. https:\/\/doi.org\/10.1038\/s41591-021-01386-7.","journal-title":"Nat Med"},{"key":"11083_CR56","doi-asserted-by":"publisher","first-page":"565","DOI":"10.1016\/S0140-6736(20)30251-8","volume":"395","author":"R Lu","year":"2020","unstructured":"Lu R, Zhao X, Li J, Niu P, Yang B, Wu H, et al. Genomic characterisation and epidemiology of 2019 novel coronavirus: implications for virus origins and receptor binding. Lancet. 2020;395:565\u201374. https:\/\/doi.org\/10.1016\/S0140-6736(20)30251-8.","journal-title":"Lancet"},{"key":"11083_CR57","unstructured":"National Clinical Laboratory Center for Quality Control in Health Industry. Discussion on \u201cfalse negative\u201d results of nucleic acid testing for SARS-CoV-2; 2020. https:\/\/www.sohu.com\/a\/373315225_100202861. Accessed 13 Mar 2023."},{"key":"11083_CR58","doi-asserted-by":"publisher","first-page":"E018","DOI":"10.3760\/cma.j.issn.1001-0939.202","volume":"43","author":"Y Peng","year":"2020","unstructured":"Peng Y, Falin S, Guijie W. Two cases of improved positive results of nucleic acid testing for SARS-CoV-2 through atomization-induced expectoration. Chin J Tuberc Respir Dis. 2020;43:E018. https:\/\/doi.org\/10.3760\/cma.j.issn.1001-0939.202.","journal-title":"Chin J Tuberc Respir Dis"},{"key":"11083_CR59","doi-asserted-by":"publisher","first-page":"1118","DOI":"10.1093\/infdis\/jiab622","volume":"225","author":"V Nussenblatt","year":"2022","unstructured":"Nussenblatt V, Roder AE, Das S, de Wit E, Youn JH, Banakis S, et al. Yearlong COVID-19 infection reveals within-host evolution of SARS-CoV-2 in a patient with B-Cell depletion. J Infect Dis. 2022;225:1118\u201323. https:\/\/doi.org\/10.1093\/infdis\/jiab622.","journal-title":"J Infect Dis"},{"key":"11083_CR60","doi-asserted-by":"publisher","DOI":"10.1016\/j.msard.2020.102439","volume":"45","author":"JR Ciotti","year":"2020","unstructured":"Ciotti JR, Valtcheva MV, Cross AH. Effects of MS disease-modifying therapies on responses to vaccinations: a review. Mult Scler Relat Disord. 2020;45: 102439. https:\/\/doi.org\/10.1016\/j.msard.2020.102439.","journal-title":"Mult Scler Relat Disord"},{"key":"11083_CR61","doi-asserted-by":"publisher","first-page":"514","DOI":"10.1016\/j.kint.2022.10.008","volume":"103","author":"JR Privratsky","year":"2023","unstructured":"Privratsky JR, Ide S, Chen Y, Kitai H, Ren J, Fradin H, et al. A macrophage-endothelial immunoregulatory axis ameliorates septic acute kidney injury. Kidney Int. 2023;103:514\u201328. https:\/\/doi.org\/10.1016\/j.kint.2022.10.008.","journal-title":"Kidney Int"},{"key":"11083_CR62","doi-asserted-by":"publisher","first-page":"28","DOI":"10.1038\/s41591-020-01202-8","volume":"27","author":"P Brodin","year":"2021","unstructured":"Brodin P. Immune determinants of COVID-19 disease presentation and severity. Nat Med. 2021;27:28\u201333. https:\/\/doi.org\/10.1038\/s41591-020-01202-8.","journal-title":"Nat Med"},{"key":"11083_CR63","doi-asserted-by":"publisher","first-page":"E66","DOI":"10.5888\/pcd18.210123","volume":"18","author":"L Kompaniyets","year":"2021","unstructured":"Kompaniyets L, Pennington AF, Goodman AB, Rosenblum HG, Belay B, Ko JY, et al. Underlying medical conditions and severe illness among 540,667 adults hospitalized with COVID-19, March 2020-March 2021. Prev Chronic Dis. 2021;18:E66. https:\/\/doi.org\/10.5888\/pcd18.210123.","journal-title":"Prev Chronic Dis"},{"key":"11083_CR64","doi-asserted-by":"publisher","first-page":"2270069","DOI":"10.1080\/22221751.2023.2270069","volume":"12","author":"JN Faraone","year":"2023","unstructured":"Faraone JN, Qu P, Goodarzi N, Zheng YM, Carlin C, Saif LJ, et al. Immune evasion and membrane fusion of SARS-CoV-2 XBB subvariants EG.5.1 and XBB.2.3. Emerg Microbes Infect. 2023;12:2270069. https:\/\/doi.org\/10.1080\/22221751.2023.2270069.","journal-title":"Emerg Microbes Infect."},{"key":"11083_CR65","doi-asserted-by":"publisher","DOI":"10.1136\/bmj.m1328","volume":"369","author":"L Wynants","year":"2020","unstructured":"Wynants L, Van Calster B, Collins GS, Riley RD, Heinze G, Schuit E, et al. Prediction models for diagnosis and prognosis of Covid-19: systematic review and critical appraisal. BMJ. 2020;369: m1328. https:\/\/doi.org\/10.1136\/bmj.m1328.","journal-title":"BMJ"},{"key":"11083_CR66","doi-asserted-by":"publisher","first-page":"428","DOI":"10.1111\/all.14657","volume":"76","author":"YD Gao","year":"2021","unstructured":"Gao YD, Ding M, Dong X, Zhang JJ, Kursat Azkur A, Azkur D, et al. Risk factors for severe and critically ill COVID-19 patients: a review. Allergy. 2021;76:428\u201355. https:\/\/doi.org\/10.1111\/all.14657.","journal-title":"Allergy"},{"key":"11083_CR67","doi-asserted-by":"publisher","first-page":"780","DOI":"10.1093\/infdis\/jiac492","volume":"227","author":"Y Nakagama","year":"2023","unstructured":"Nakagama Y, Candray K, Kaku N, Komase Y, Rodriguez-Funes MV, Dominguez R, et al. Antibody avidity maturation following recovery from infection or the booster vaccination grants breadth of SARS-CoV-2 neutralizing capacity. J Infect Dis. 2023;227:780\u20137. https:\/\/doi.org\/10.1093\/infdis\/jiac492.","journal-title":"J Infect Dis"},{"key":"11083_CR68","doi-asserted-by":"publisher","first-page":"1699","DOI":"10.3390\/vaccines10101699","volume":"10","author":"D Tian","year":"2022","unstructured":"Tian D, Nie W, Sun Y, Ye Q. The epidemiological features of the SARS-CoV-2 omicron subvariant BA.5 and its evasion of the neutralizing activity of vaccination and prior infection. Vaccines (Basel). 2022;10:1699. https:\/\/doi.org\/10.3390\/vaccines10101699.","journal-title":"Vaccines (Basel)."},{"key":"11083_CR69","doi-asserted-by":"publisher","first-page":"eadj5154","DOI":"10.1126\/scitranslmed.adj5154","volume":"16","author":"HV Phan","year":"2024","unstructured":"Phan HV, Tsitsiklis A, Maguire CP, Haddad EK, Becker PM, Kim-Schulze S, et al. Host-microbe multiomic profiling reveals age-dependent immune dysregulation associated with COVID-19 immunopathology. Sci Transl Med. 2024;16:eadj5154. https:\/\/doi.org\/10.1126\/scitranslmed.adj5154.","journal-title":"Sci Transl Med."},{"key":"11083_CR70","doi-asserted-by":"publisher","first-page":"1412","DOI":"10.1056\/NEJMoa2101765","volume":"384","author":"N Dagan","year":"2021","unstructured":"Dagan N, Barda N, Kepten E, Miron O, Perchik S, Katz MA, et al. BNT162b2 mRNA Covid-19 vaccine in a nationwide mass vaccination setting. N Engl J Med. 2021;384:1412\u201323. https:\/\/doi.org\/10.1056\/NEJMoa2101765.","journal-title":"N Engl J Med"}],"container-title":["BMC Infectious Diseases"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12879-025-11083-2.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s12879-025-11083-2\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12879-025-11083-2.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,5,14]],"date-time":"2025-05-14T11:36:17Z","timestamp":1747222577000},"score":1,"resource":{"primary":{"URL":"https:\/\/bmcinfectdis.biomedcentral.com\/articles\/10.1186\/s12879-025-11083-2"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,5,14]]},"references-count":70,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2025,12]]}},"alternative-id":["11083"],"URL":"https:\/\/doi.org\/10.1186\/s12879-025-11083-2","relation":{},"ISSN":["1471-2334"],"issn-type":[{"value":"1471-2334","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,5,14]]},"assertion":[{"value":"10 January 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"5 May 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"14 May 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The study was conducted in accordance with the principles outlined in the Declaration of Helsinki. The study protocol outlined in our manuscript has been thoroughly reviewed and approved by the Ethics Committee of Aerospace Center Hospital, with the approval number being Jinghang Yilun Shen 2024 No. 090. Notably, in accordance with the committee\u2019s guidelines and the nature of our study, the requirement for informed consent was formally waived by the Ethics Committee of Aerospace Center Hospital for all participants involved. Additionally, we wish to clarify that this is a retrospective study; therefore, this declaration is \u201cnot applicable.\u201d We kindly request that our manuscript be considered in accordance with these statements.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Not applicable.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare no competing interests.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"699"}}